joe rogan on semaglutide for the People Are GLP-1s Performance-Enhancing Drugs? -

GLP-1 generic pricing dynamics and accessibility challenges In previous years, high prices limited GLP-1 therapies to affluent segments

They are obesity-focused, not metabolic medicine-focused

W.WangJ

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your individual predispositions in GLP-1 pathway variantsspecifically GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313before selecting a treatment program

Lancet Neurol

A: Research suggests 500-510 mg daily may help with narcolepsy, but effects on general sleep quality are not well-established